HbA1c and Troponin-I Levels and Their Relationship in Patients with Acute Coronary Syndrome

M S Hossain1, F Sharmin, I Sultana

  • 1Dr Muhammad Shakhawat Hossain, Lecturer, Department of Biochemistry, Mymensingh Medical College (MMC), Mymensingh, Bangladesh; dr.md.shakhawat17@gmail.com.

Insights

Diabetic patients with acute coronary syndrome show higher levels of glycated hemoglobin (HbA1c) and cardiac Troponin-I. Elevated HbA1c is linked to increased Troponin-I, indicating greater cardiac injury in these patients.

Area of Science:

  • Cardiology
  • Endocrinology
  • Biochemistry

Background:

  • Acute coronary syndrome (ACS) poses a significant public health challenge, particularly for diabetic individuals who face accelerated atherosclerosis and higher mortality risks.
  • Elevated glycated hemoglobin (HbA1c) is recognized as an independent risk factor for ACS in patients with diabetes mellitus.
  • Troponin-I serves as a critical biomarker for detecting cardiac muscle injury.

Purpose of the Study:

  • To investigate the relationship between HbA1c levels and Troponin-I levels in patients diagnosed with acute coronary syndrome.
  • To compare these markers in patients with and without diabetes mellitus.

Main Methods:

  • A cross-sectional study involving ninety-five patients admitted to the cardiology department of the National Institute of Cardiovascular Diseases, Dhaka.
  • Patients were categorized into two groups: ACS with diabetes mellitus (Group A) and ACS without diabetes mellitus (Group B).
  • HbA1c and Troponin-I levels were analyzed and correlated with clinical parameters.

Main Results:

  • Group A (ACS with diabetes) exhibited significantly higher mean HbA1c (p=0.001) and Troponin-I levels (p=0.023) compared to Group B (ACS without diabetes).
  • A significant positive correlation (r=0.471, p=0.001) was observed between HbA1c and Troponin-I levels within Group A.
  • Mean systolic blood pressure (SBP) and diastolic blood pressure (DBP) were also significantly higher in Group A.

Conclusions:

  • The study confirms a significant positive correlation between elevated HbA1c and Troponin-I levels in diabetic patients experiencing acute coronary syndrome.
  • These findings underscore the heightened cardiac muscle injury and risk associated with poor glycemic control in ACS patients.
  • HbA1c serves as a valuable indicator of cardiac injury severity in diabetic individuals with ACS.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
229
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
20
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
56
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
33
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
138
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
20